CLEVELAND, March 19, 2012 /PRNewswire-USNewswire/ -- The nation's first Minority Biomedical Entrepreneurship Conference (MBEC), will convene May 21-22 in Cleveland. MBEC offers a unique platform for minority professionals, entrepreneurs, investors, students and industry leaders to engage, network, collaborate and exchange ideas.
Minorities represent less than 5 percent(1) of the growing biomedical industry workforce, and a fraction of that number engages in entrepreneurial endeavors. To address the issue of underrepresentation, and to increase minority competitiveness in the biomedical industry, The America21 Project, a minority innovation and competitiveness initiative, and BioEnterprise, a biomedical business accelerator, partnered to created MBEC. The intent is to hold the conference annually.
Keynoting the conference is Dr. Frank Douglas, President of the Austen BioInnovation Institute and former Executive Vice President and Chief Scientific Officer of Aventis. A national steering committee of Hispanic and African-American leaders in the biomedical industry – including Guy Fish, Vice President Fletcher Spaght Ventures (Boston); Ron Foy, Managing Director Cambria Capital (San Francisco); and Marissa Trevino, Founder Latina Lista (Dallas)- guide the conference mission and direct the agenda. A nationally-recognized speaker line-up – including Dr. William L. Daley, Vice President Business Development & Licensing, U.S. Medical Affairs, Sanofi (New Jersey); and Monica Sturgis, HR Business Partner, Boehringer-Ingelheim (Cleveland) – complete an inspired conference agenda.
"Cleveland, with its rapidly growing biomedical industry and nationally recognized research, clinical and educational institutions, is the ideal location for the first-ever Minority Biomed
|SOURCE BioEnterprise Corporation|
Copyright©2010 PR Newswire.
All rights reserved